Walleye Capital
BMY icon

Walleye Capital’s Bristol-Myers Squibb BMY Stock Holding History

Walleye Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.26M Sell
53,800
-385,500
-88% -$22.5M 0.01% 1076
2025
Q4 		$23.7M Buy
439,300
+268,000
+156% +$12.9M 0.07% 234
2025
Q3 		$7.73M Buy
171,300
+9,800
+6% +$458K 0.03% 666
2025
Q2 		$7.48M Buy
161,500
+22,200
+16% +$1.09M 0.03% 643
2025
Q1 		$8.5M Sell
139,300
-79,500
-36% -$4.63M 0.04% 513
2024
Q4 		$12.4M Sell
218,800
-78,100
-26% -$4.36M 0.03% 512
2024
Q3 		$15.4M Sell
296,900
-328,600
-53% -$15.4M 0.03% 459
2024
Q2 		$26M Buy
625,500
+352,200
+129% +$15.8M 0.05% 270
2024
Q1 		$14.8M Sell
273,300
-143,900
-34% -$7.33M 0.03% 581
2023
Q4 		$21.4M Sell
417,200
-35,900
-8% -$1.88M 0.05% 300
2023
Q3 		$26.3M Buy
453,100
+304,700
+205% +$18.7M 0.07% 173
2023
Q2 		$9.49M Buy
148,400
+71,400
+93% +$4.79M 0.03% 424
2023
Q1 		$5.34M Buy
77,000
+12,400
+19% +$875K 0.08% 303
2022
Q4 		$4.65M Sell
64,600
-39,500
-38% -$2.98M 0.08% 283
2022
Q3 		$7.4M Buy
+104,100
New +$7.55M 0.14% 156
2020
Q1 		– Sell
-96,400
Closed -$6.19M – 971
2019
Q4 		$6.19M Buy
96,400
+17,700
+22% +$1.01M 0.4% 28
2019
Q3 		$3.99M Buy
78,700
+37,000
+89% +$1.74M 0.24% 77
2019
Q2 		$1.89M Buy
41,700
+41,000
+5,857% +$1.91M 0.21% 107
2019
Q1 		$33K Buy
+700
New +$34.9K 0.01% 1284

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Walleye Capital's BMY Position: Q1 2026 in Review

Walleye Capital reduced its Bristol-Myers Squibb (BMY) stake by 100% in Q1 2026, selling an estimated $1.47M and leaving 78 shares worth $4.73K. The position accounts for ﹤0.01% of the portfolio, ranked #4200.

Walleye Capital first reported a position in BMY in Q1 2019 and has held it in 17 quarters since. The position peaked at $13M in Q3 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Walleye Capital held 78 shares of Bristol-Myers Squibb worth $4.73K as of Q1 2026.
  • Walleye Capital sold 25,141 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.47M.
  • Bristol-Myers Squibb made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4200 holding.
  • Walleye Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 17 quarters since.
  • Walleye Capital's Bristol-Myers Squibb position peaked at $13M in Q3 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.